- Home
- SLGL vs NHIV Comparison
SLGL vs NHIV Comparison
Compare SLGL & NHIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLGL | NHIV |
|---|---|---|
| Founded | 1997 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.1M | 276.5M |
| IPO Year | 2016 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SLGL | NHIV |
|---|---|---|
| Price | $70.39 | $10.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $110.00 | N/A |
| AVG Volume (30 Days) | ★ 57.5K | 7.5K |
| Earning Date | 05-22-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $223.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.15 | $9.96 |
| 52 Week High | $97.97 | $10.16 |
Technical Indicators
Market Signals| Indicator | SLGL | NHIV |
|---|---|---|
| Relative Strength Index (RSI) | 40.03 | 60.44 |
| Support Level | $67.89 | $10.05 |
| Resistance Level | $81.18 | $10.16 |
| Average True Range (ATR) | 5.13 | 0.01 |
| MACD | -1.16 | -0.00 |
| Stochastic Oscillator | 17.86 | 42.86 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
About NHIV NewHold Investment Corp IV Class A Ordinary Shares
NewHold Investment Corp IV is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.